Cav2.2 is also upregulated in demyelinating areas [103], but its blocker pregabalin, prescribed to treat neuropathic pain in MS patients [62,63], might rise concerns about memory impairment, as it decreases LTP in mice and working memory in humans [63,64,65]. Here, CACNA1B is linked to myeloid sarcoma.